Finding ways to improve immune responses in head and neck cancers

Who could benefit from this research

What this research studies

This research focuses on head and neck squamous cell carcinoma (HNSCC), a type of cancer that has limited treatment options. The project aims to enhance the effectiveness of immunotherapy, which has shown some success but only benefits a small number of patients. Researchers will investigate the reasons behind the immune system's failure to respond to tumors and develop new strategies to overcome these barriers. By understanding both the tumor's characteristics and the immune system's suppression, the goal is to create innovative treatment combinations that can help more patients respond positively to immunotherapy.

Why it matters

Where this research is happening

• Yale University
  New Haven, United States Active

Researchers

• Principal investigator: Pai, Sara Isabel — Yale University
• Study coordinator: Pai, Sara Isabel

Related research

Other NIH-funded projects on the same topics.

• Targeting mitochondria with a ceramide compound to treat head and neck cancer

  A new drug candidate called LCL768 aims to kill head and neck cancer cells by targeting their mitochondria and could also boost how well immunotherapy works.

  NIH research Lipo-Immuno Tech, LLC · Mount Pleasant, United States · NIH-11404364

• How some p53 gene changes help head and neck cancers spread and hide from the immune system

  Researchers are looking at whether blocking a protein called MCM5 can stop p53‑mutant head and neck cancers from becoming unstable, spreading, and weakening the immune system.

  NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11300228

• Combining Cue-101 and engineered T cells to treat HPV-positive head and neck cancer

  Doctors are combining Cue-101 with specially engineered T cells to help people with HPV16-positive head and neck cancer by improving tumor targeting while using lower cell doses.

  NIH research Yale University · New Haven, United States · NIH-11294142

• Combining T cell therapy with a new treatment for HPV-related head and neck cancers

  This study is testing a new way to treat head and neck cancers linked to HPV by using specially modified immune cells that can find and fight the cancer, and it's for patients with HPV-positive cancers who want to explore a promising treatment option.

  NIH research Yale University · New Haven, United States · NIH-11038001

• How mutations in the TP53 gene affect cancer spread and immune response in head and neck cancers

  This study is looking at certain changes in a gene called TP53 that are often found in head and neck cancers to see how they affect how the cancer grows and avoids the immune system, with the hope of finding new treatments that could work better for patients like you.

  NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11034107

• Using nanoscale frameworks to enhance cancer treatment and immunotherapy for head and neck cancers

  This study is exploring a new way to help people with head and neck cancers by using tiny materials that can boost radiation therapy and help the immune system fight the cancer better, aiming to improve treatment results and survival rates for patients.

  NIH research University of Chicago · Chicago, United States · NIH-10885971

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.